Fulcrum plans to float on AIM

Fulcrum Pharma (Hemel Hempstead, U.K.), a virtual drug development company, plans to raise 1.2 million ($1.9 million) through an IPO on AIM giving it a market cap up to 2 million. Seymour Pierce is th...